EFM R&D S.A.

EFM R&D S.A. is a Polish technology company, founded in 2022, developing solutions for the medical sector. The company's main focus is on accelerating the diagnosis of cardiovascular diseases (CVD) through its primary product, the Mudisocard system. This telemedical device is designed to enable the immediate diagnosis of critical heart conditions, addressing the often lengthy process of reaching a conclusive diagnosis which can take weeks or months.

The Mudisocard system measures multiple heart parameters simultaneously. It captures the heart's contraction excitation (ECG), details of the contraction's development (auscultation), and the resulting movement of chest fluids (bioimpedance). This collected data is sent to a web platform where specialized algorithms analyze it, allowing healthcare professionals to assess heart parameters instantly. By comparing each heartbeat, the algorithms can detect subtle changes in the heart's electrical and mechanical dynamics that may indicate heart disease. This approach aims to streamline clinician workflows and reduce the need for numerous, costly medical tests.

Since its inception, EFM has developed a functional prototype of the Mudisocard system and has filed for patents in the European Union, the United States, the UAE, Saudi Arabia, and South Korea. The company has also achieved ISO 13485:2016 certification for its quality management system, a significant step for the commercialization of its medical device. The leadership team includes CEO Miłosz Jamroży, a medical doctor with a PhD in Biomedical Engineering and over a decade of experience in telemedicine product development, CFO Filip Janowski, CTO Aleksander Cudny, and Quality & Regulatory Affairs Director Karol Pawelec. The company is venture capital-backed, with investors including WorldUpstart, StartSmart CEE, and TERRA seed, and is considering future financing options, including an IPO, to fund upcoming milestones.

Keywords: cardiovascular diagnostics, telemedical device, heart condition diagnosis, medical algorithms, ECG analysis, bioimpedance, heart auscultation, medtech, healthcare technology, telemedicine, cardiovascular disease, heart failure diagnosis, Mudisocard, remote patient monitoring, diagnostic equipment, medical device, AI in healthcare, clinical decision support, non-invasive diagnostics, heart monitoring